scPharmaceuticals to Participate in the Jefferies London Healthcare Conference

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH), a company focused on optimizing infused therapies, will have its President & CEO, John Tucker, present at the Jefferies London Healthcare Conference on November 16 at 5:35 pm GMT (12:35 pm ET). The event will be accessible via a live webcast in the Investor Relations section of their website. The company specializes in developing products to reduce healthcare costs and improve patient outcomes, particularly in heart failure and infectious diseases.

BURLINGTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to present at the Jefferies London Healthcare Conference, on Wednesday, November 16 at 5:35 pm GMT (12:35 pm ET).

A live webcast of the fireside chat can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com

FAQ

When is scPharmaceuticals' presentation at the Jefferies London Healthcare Conference?

scPharmaceuticals' presentation is scheduled for November 16 at 5:35 pm GMT (12:35 pm ET).

Who will present for scPharmaceuticals at the Jefferies Conference?

John Tucker, President & CEO of scPharmaceuticals, will present at the Jefferies Conference.

Where can I watch the scPharmaceuticals presentation?

You can watch the live webcast of the presentation on the Investor Relations section of scPharmaceuticals' website.

What is the focus of scPharmaceuticals’ product development?

scPharmaceuticals focuses on reducing healthcare costs and improving health outcomes through innovative treatments for conditions like heart failure and infectious diseases.

What is the stock symbol for scPharmaceuticals?

The stock symbol for scPharmaceuticals is SCPH.